SNCA and Alzheimer disease: Evaluating whether non-AD pathology may be present is an important question, particularly in elderly individuals with cognitive problems, and additional biomarkers could be helpful if they inform about processes, such as alpha-Synuclein, TDP-43, or vascular brain pathology.